CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026
Globe Newswire•06/11/2026•08:30 ET
0
Key Highlights
- ➤CorMedix will report Q3 2026 financial results before market open November 12
- ➤Corporate update conference call scheduled for 8:30 a.m. EST November 12
- ➤CorMedix Therapeutics (CRMD) markets products for life-threatening conditions in U.S. institutional care settings
PARSIPPANY, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the third quarter ended September 30, 2026, before the market opens on Thursday, November 12, 2026, and will host a corporate update conference call at 8:30 a.m. Eastern Standard Time.
Thursday, November 12 (th)at 8:30 a.m. EST Domestic: 1-844-676-2922 International: 1-412-634-6840 Webcast: Webcast Link
Get started
Create a free account to read the full story.